MedTrace Logo

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

NCT01600404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2015-11-17

No results posted yet for this study

Summary

Prospective evaluation of the cognitive function of in-house patients suffering from an acute traumatic spinal cord injury before and three months after the initiation of antimuscarinic treatment.

The following hypothesis will be tested: Antimuscarinic treatment results in significantly worse cognitive test results three months after traumatic spinal cord injury compared to the pre-treatment results and the results of the control group.

Conditions

Interventions

DRUG

antimuscarinic treatment

Sponsors & Collaborators

  • Swiss Paraplegic Research, Nottwil

    lead NETWORK

Principal Investigators

  • Jürgen Pannek, Prof · Swiss Paraplegic Centre

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01600404 on ClinicalTrials.gov